ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Invesco Variable Rate Preferred ETF

Invesco Variable Rate Preferred ETF (VRP)

24.27
0.02
(0.08%)
Closed January 25 4:00PM
24.27
0.00
(0.00%)
After Hours: 4:01PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
24.27
Bid
-
Ask
-
Volume
361,036
24.2419 Day's Range 24.29
23.275 52 Week Range 24.67
Market Cap
Previous Close
24.25
Open
24.29
Last Trade
4441
@
24.27
Last Trade Time
Financial Volume
$ 8,761,398
VWAP
24.2674
Average Volume (3m)
426,332
Shares Outstanding
72,100,000
Dividend Yield
-
PE Ratio
8.75
Earnings Per Share (EPS)
2.77
Revenue
95.49M
Net Profit
200.05M

About Invesco Variable Rate Preferred ETF

The investment seeks to track the investment results (before fees and expenses) of the Wells Fargo Hybrid and Preferred Securities Floating and Variable Rate Index. The fund will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is a m... The investment seeks to track the investment results (before fees and expenses) of the Wells Fargo Hybrid and Preferred Securities Floating and Variable Rate Index. The fund will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is a market capitalization-weighted index designed to track the performance of preferred stock, as well as certain types of hybrid securities that are functionally equivalent to preferred stocks, that are issued by U.S.-based or foreign issuers and that pay a floating or variable rate dividend or coupon. It is non-diversified. Show more

Sector
Mgmt Invt Offices, Open-end
Industry
Mgmt Invt Offices, Open-end
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Invesco Variable Rate Preferred ETF is listed in the Mgmt Invt Offices, Open-end sector of the American Stock Exchange with ticker VRP. The last closing price for Invesco Variable Rate Pr... was $24.25. Over the last year, Invesco Variable Rate Pr... shares have traded in a share price range of $ 23.275 to $ 24.67.

Invesco Variable Rate Pr... currently has 72,100,000 shares outstanding. The market capitalization of Invesco Variable Rate Pr... is $1.75 billion. Invesco Variable Rate Pr... has a price to earnings ratio (PE ratio) of 8.75.

VRP Latest News

Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update

LONDON and RALEIGH, N.C., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

CORRECTING and REPLACING -- Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD

LONDON and RALEIGH, N.C., Feb. 02, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Verona Pharma plc (Nasdaq: VRNA), please note that all instances of the...

Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD

Primary and secondary lung function endpoints met Results support twice-daily dosing LONDON and RALEIGH, N.C., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona...

Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19

LONDON and RALEIGH, N.C., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

Verona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference

LONDON and RALEIGH, N.C., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

Verona Pharma Announces November 2020 Virtual Investor Conference Participation

LONDON and RALEIGH, N.C., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020

Initiated ENHANCE Phase 3 clinical trials in COPD Completed $200 million private placement Commenced a pilot clinical study in U.S. patients hospitalized with COVID-19 Conference call today at...

Verona Pharma to Announce Interim Results for the Three and Nine Months Ended September 30, 2020 and Provide Corporate Update...

LONDON and RALEIGH, N.C., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory...

Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020

LONDON and RALEIGH, N.C., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory...

Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19

LONDON and RALEIGH, N.C., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.08-0.32854209445624.3524.3824.261498424.27109632SP
4-0.01-0.041186161449824.2824.461224.0457219724.23014353SP
12-0.14-0.57353543629724.4124.5824.0442633224.34095741SP
260.251.0407993338924.0224.6723.4338556024.269752SP
520.994.2525773195923.2824.6723.27538424824.00649217SP
156-1.35-5.2693208430925.6225.6620.87543474123.17856379SP
260-1.72-6.6179299730725.9926.513.3340339923.74132048SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NVNINVNI Group Ltd
$ 4.38
(193.96%)
366.98M
EVAXEvaxion Biotech AS
$ 5.99
(64.56%)
55.41M
ELABPMGC Holdings Inc
$ 3.0901
(56.07%)
76.48M
PCLAPicoCELA Inc
$ 4.60
(49.35%)
3.75M
GOEVCanoo Inc
$ 0.475
(43.94%)
282.22M
GODNUGolden Star Acquisition Corporation
$ 3.11
(-75.82%)
17.51k
GODNGolden Star Acquisition Corporation
$ 2.93
(-65.67%)
902.76k
NXTTNext Technology Holding Inc
$ 1.37
(-54.93%)
2.56M
SGLYSingularity Future Technology Ltd
$ 1.625
(-38.45%)
917.77k
WHLRLWheeler Real Estate Investment Trust Inc
$ 90.11
(-38.07%)
8
ACONAclarion Inc
$ 0.0557
(28.94%)
811.91M
NVNINVNI Group Ltd
$ 4.38
(193.96%)
366.98M
RIMEAlgorhythm Holdings Inc
$ 0.0357
(4.69%)
284.97M
GOEVCanoo Inc
$ 0.475
(43.94%)
282.22M
NVDANVIDIA Corporation
$ 142.62
(-3.12%)
232.88M

Discussion

View Full Feed
frrol frrol 1 minute ago
Week 0 that is first dose. The 462 is likely those who made it to first testing ("follow up") visit. That can still be considered "mITT", which has a loose definition.
AVXL
MC10459 MC10459 1 minute ago
I do as well, but it doesn't show any dollar value attributed to them a this point.
BDPT
Monksdream Monksdream 2 minutes ago
BYRN
https://investorshub.advfn.com/uimage/uploads/2025/1/25/rkgxgIMG_4794.gif
BYRN
DesertDrifter DesertDrifter 2 minutes ago
California citrus farmers report that thousands of workers didn’t show up today. Acres of oranges, limes, and lemons are rotting as harvest season is ‘virtually halted’

Dumbass trump is really bringing the price of food down... not. His indiscriminate detaining of farm workers is set
Monksdream Monksdream 4 minutes ago
TSSI
https://investorshub.advfn.com/uimage/uploads/2025/1/25/pfmdiIMG_4792.gif
TSSI
Windbag1014 Windbag1014 4 minutes ago
He may be. I hope so if he is going to lead my country.

Your libtard comment, although childish and unhelpful, is a great example of why politics in the US is in the state it is today. There seems to be a need to belong to the blue cult or the red cult. I do my best to look out f
LCID
fza fza 5 minutes ago
From what I've read about angel investors some want a voice in the operation. Many you on this board would know the percentages of these investors who require this. But there has to be some I would suspect that would be hands off, so Mojo poses a good question of why not use them. Depending on ho
KBLB
RickNagra RickNagra 5 minutes ago
https://www.reuters.com/world/us/senate-may-vote-trump-treasury-nominee-bessent-this-weekend-top-republican-says-2025-01-23/
FNMA
Make It Jake Make It Jake 6 minutes ago
Current AIM-CASH weekly values

S&P 500 : 55.6% – A proxy for large- and mega-cap stocks
This is a decrease from last week’s value. Percent rank : 88.3

S&P 400 : 59.8% – A proxy for mid-cap stocks
This is a decrease from last week’s value. Percent rank :
stockprofitter stockprofitter 6 minutes ago
Stupid - there can’t be more warrants.
FNMA
StockItOut StockItOut 7 minutes ago
Correct! I just proved it.
XERI
dbob dbob 7 minutes ago
you told everyone you are on this thread 5 minutes a day. You meant 5 hours pal. admit it. Your life is wasting away on pure negativity.
HIRU
Jackxkr Jackxkr 8 minutes ago
Going to be interesting to follow Lisa's husband's journey with gbm on twitter. He is on a treatment of dvax, poly icic and keytruda.
NWBO
HomerRomer HomerRomer 8 minutes ago
Here is the link...
AVXL
StockItOut StockItOut 8 minutes ago
Correct! You just proved it.


Finally, Quester proved something!

.
XERI
StockSeedGems2143 StockSeedGems2143 9 minutes ago
Merger possibility ? Food for thought, imo. Source : esos.nv.gov. Note " President" below.
Entity Name:PHOENIX GLOBAL TECHNOLOGY, INC.Entity Number:E15069372021-2
Entity Type:Domestic Corporation (78)Entity Status:Active
Formation Date:06/04/2021NV Business ID:NV20212117434
TMMI
RickNagra RickNagra 9 minutes ago
Oh wow.  Today will be a great day.  Oh wow.  Oh boy oh girl.
DBMM
dbob dbob 9 minutes ago
Your just a delusional human. You probably think the new President is great too.
HIRU
3331 3331 10 minutes ago
BIEL: HUGE! Sree Koneru, PhD's appointment to the Board of Directors at BioElectronics Corporation is a strategic move that will likely contribute to the company's growth and innovation in the medical technology sector. His expertise in neuromodulation device development and regulatory submissions,
HomerRomer HomerRomer 10 minutes ago
https://www.linkedi
AVXL
Nebuchadnezzar Nebuchadnezzar 10 minutes ago
I hear RITE could be big!!!

how big do you fellow traders and investors think RITE could be??

out of posts
RITE
StockItOut StockItOut 11 minutes ago
Correct! You ask AI stupid misdirectioned questions to meet your predetermined bias.

predetermined bias = fascist = maga = lame!
XERI

Your Recent History

Delayed Upgrade Clock